Skip to content
20-F

Annual Report (Foreign)

CLEMENTIA PHARMACEUTICALS INC.

0001171843-19-002074

← back to feed
Filed
Mar 29, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2018 · Dec 31, 2018 37.86M sh
Operating Cash Flow FY 2018 · Dec 31, 2018 −$49.14M
Operating Cash Flow FY 2018 · Dec 31, 2017 −$35.57M
Operating Cash Flow FY 2018 · Dec 31, 2016 −$18.83M
Cash And Equivalents FY 2018 · Dec 31, 2018 $94.97M
Cash And Equivalents FY 2018 · Dec 31, 2017 $36.23M
Cash And Equivalents FY 2018 · Dec 31, 2016 $9.43M
Cash And Equivalents FY 2018 · Dec 31, 2015 $58.11M
Stockholders Equity FY 2018 · Dec 31, 2018 $164.43M
Stockholders Equity FY 2018 · Dec 31, 2017 $141.71M
Stockholders Equity FY 2018 · Dec 31, 2016 −$148.67M
Stockholders Equity FY 2018 · Dec 31, 2015 −$91.33M
Current Liabilities FY 2018 · Dec 31, 2018 $12.41M
Current Liabilities FY 2018 · Dec 31, 2017 $6.72M
Current Assets FY 2018 · Dec 31, 2018 $174.14M
Current Assets restated FY 2018 · Dec 31, 2017 $70.9M
Total Assets FY 2018 · Dec 31, 2018 $176.84M
Total Assets FY 2018 · Dec 31, 2017 $148.43M
Rd Expense FY 2018 · Dec 31, 2018 $43.9M
Rd Expense FY 2018 · Dec 31, 2017 $27.41M
Rd Expense FY 2018 · Dec 31, 2016 $16.85M
Net Income FY 2018 · Dec 31, 2018 −$58.13M
Net Income FY 2018 · Dec 31, 2017 −$115.46M
Net Income FY 2018 · Dec 31, 2016 −$57.51M